Literature DB >> 4093607

Brucellosis: serological methods compared.

W Heizmann, K Botzenhart, G Döller, D Schanz, G Hermann, K Fleischmann.   

Abstract

At least 12 persons contracted clinical, and 4 persons subclinical Brucella melitensis infection during a brucellosis epidemic in the spring and summer of 1983 in Southern Germany, a region which had been free of this disease for the past 20 years. All cases of illness were traced to one infected herd of sheep. The presence of antibodies against B. melitensis was examined in 72 sera of infected patients using the following tests: agglutination, Coomb's test, two complement fixation tests with different antigen preparations (CFT 1 and 2), IgG and IgM enzyme-linked immunosorbent assay (ELISA), and opsonophagocytosis; and the occurrence of cross-reacting antibodies against Yersinia enterocolitica O 9 was investigated in the agglutination and complement fixation tests. Sera from 100 blood donors and 112 other people with close contact with sheep were also examined. The results revealed the need to consider an intermediate range in the interpretation of ELISA results--due to elevated values of persons in groups at risk but without clinical signs of illness. In all other tests, however, such persons revealed the same cut-off levels as the general population. Results from all initial sera of infected persons revealed titres of optical densities above the baseline levels determined in the present study, with the exception of the Coomb's and CFT2 tests. The agglutination test, but not brucella CFT2, revealed complete cross-reactivity between Y. enterocolitica O 9 and B. melitensis. ELISA stood out as the only test which is suited to diagnosis of both recent and past infection, since ELISA IgM determination permits conclusions about the time of the onset of illness, and determination of IgG may still yield values above the cut-off level up to 623 days after the onset of illness. In 2 of the 16 infected persons, IgG ELISA was the only test revealing previous infection 424 and 528 days after the onset of illness. A procedural scheme is presented which may help to simplify the diagnosis of brucellosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4093607      PMCID: PMC2129560          DOI: 10.1017/s0022172400060745

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  8 in total

1.  Marked cross-agglutination between Brucellae and a subtype of Yersinia enterocolitica.

Authors:  P Ahvonen; E Jansson; K Aho
Journal:  Acta Pathol Microbiol Scand       Date:  1969

2.  [Lumbar spondylitis in brucellosis].

Authors:  W Heizmann; K Botzenhart; A Heber
Journal:  Dtsch Med Wochenschr       Date:  1984-03-16       Impact factor: 0.628

3.  Diagnosis of human brucellosis with ELISA.

Authors:  J E Sippel; N A El-Masry; Z Farid
Journal:  Lancet       Date:  1982-07-03       Impact factor: 79.321

4.  The serological relationship between Brucella spp., Yersinia enterocolitica serotype IX and Salmonella serotypes of Kauffmann-White group N.

Authors:  M J Corbell
Journal:  J Hyg (Lond)       Date:  1975-08

5.  Measurement of immunoglobulin M, immunoglobulin G, and immunoglobulin A antibodies against Yersinia enterocolitica by enzyme-linked immunosorbent assay: comparison of lipopolysaccharide and whole bacterium as antigen.

Authors:  K Granfors; M K Viljanen; A Toivanen
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

6.  An enzyme-labelled immunosorbent assay for Brucella abortus antibodies.

Authors:  J T Magee
Journal:  J Med Microbiol       Date:  1980-02       Impact factor: 2.472

7.  Enzyme immunoassay of the antibody response to Brucella and Yersinia enterocolitica 09 infections in humans.

Authors:  A A Lindberg; S Haeggman; K Karlson; H E Carlsson; N S Mair
Journal:  J Hyg (Lond)       Date:  1982-04

8.  Radioimmunoassay of IgM, IgG, and IgA Brucella antibodies.

Authors:  D Parratt; K H Nielsen; R G White
Journal:  Lancet       Date:  1977-05-21       Impact factor: 79.321

  8 in total
  4 in total

1.  Evaluation of the PANBIO Brucella immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays for diagnosis of human brucellosis.

Authors:  George F Araj; Mireille M Kattar; Layla G Fattouh; Kayane O Bajakian; Sara A Kobeissi
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

2.  Seroprevalence of brucella antibodies among persons in high-risk occupation in Lebanon.

Authors:  G F Araj; R A Azzam
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

3.  [A rare cause of infection in chronic dialysis patients: Malta fever (febris undulans melitensis)].

Authors:  V Stich-Kreitner; C Piper; H H Schassan; H von Egidy
Journal:  Klin Wochenschr       Date:  1988-08-15

4.  Tolerance of the human brucellosis vaccine and the intradermal reaction test for brucellosis.

Authors:  C Hadjichristodoulou; P Voulgaris; L Toulieres; T Babalis; S Manetas; G Goutziana; I Kastritis; I Tselentis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-02       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.